• COVID-19 mRNA Vaccine COMIRNATY®
  • Mechanism of mRNA
  • SARS-CoV-2
  • The second vaccination
  • project-lightspeed
  • additional-information
  • Reporting side effects
    • Deutsch
    • English / Englisch
    • Español / Spanisch
    • Français / Französisch
    • Italiano / Italienisch
    • Kurdî (Kurmancî) / Kurdisch (Kurmandschi)
    • Русский / Russisch
    • Polski / Polnisch
    • Türkçe / Türkisch
    • Ελληνικά / Griechisch
    • Български / Bulgarisch
    • Hrvatski / Kroatisch
    • Українська / Ukrainisch

    BioNTech Europe GmbH
    An der Goldgrube 12
    55131 Mainz / Deutschland

    T.: +49 6131 9084-0
    F: +49 6131 9084-2121
    M: service@biontech.de
    W: service.biontech.de

    Our vision: We aspire to utilize the full potential of the immune system to fight cancer and infectious diseases.

    Company
    Our DNA How we translate Science Connect Investors & Media Careers
    Resources
    Report a side effect Subscribe to our info service
    Terms of Use General Terms and Conditions General Conditions of Purchase Data Privacy Statement Data Processing Terms for Business Partners Imprint
    Twitter
    Linkedin

    © Copyright BioNTech Europe 2022. All Rights Reserved.

    48101

    Cookie–Settings